Evidence Summary
- Evidence Level
- Preliminary
- Mechanism
- Enrollment: Actual, Sponsor Type: Other, Unknown / General
- Safety
- Limited specific safety data in these populations. Review full prescribing information and consult specialist. Many agents used off-label or investigational.
- Dosing
- See linked studies/trials for reported doses and durations; typical protocols vary widely.
Creatine monohydrate 5g daily. RCT evidence (d~1) for mental fatigue and concentration in PASC. Mitochondrial support. Safe for most; monitor renal and fluid retention.
Clinical Trials
1 trial(s) registered
| NCT ID | Title | Phase | Status |
|---|---|---|---|
| NCT02374112 | Creatine Supplementation in Chronic Fatigue Syndrome | Not applicable | Active, not recruiting |
Key Studies / References
- See linked studies